Jaguar Health Shareholder Meeting
Jaguar Health held a special meeting of stockholders on November 6, 2026, where all six submitted proposals were approved. Key approvals included the issuance of common stock upon exchange of Series Q Preferred Stock and debt, the repricing of investor warrants to $1.00 per share, an increase in authorized shares for the 2014 Stock Incentive Plan, and the authorization for a potential reverse stock split at a ratio between 1-for-2 and 1-for-150.